Evidence map›Paper›PMID 35199752›Full record

ArticleJNMA; journal of the Nepal Medical Association2021

Sputum Smear Non-conversion at the End of Intensive Phase of Tuberculosis Treatment at a Tertiary Center: A Descriptive Cross-sectional study.

Naveen Prakash Shah, Anil Regmi, Aakash Acharya, Jwala K C, Bidur Khatiwada, Meera Hada

Open access · diamondAbstract read
In one paragraph

Article in JNMA; journal of the Nepal Medical Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Naveen Prakash ShahDepartment of Pulmonology, National Tuberculosis Control Center, Sanothimi, Bhaktapur, Nepal.
Anil RegmiDepartment of Pulmonology, National Tuberculosis Control Center, Sanothimi, Bhaktapur, Nepal.
Aakash AcharyaDepartment of Pulmonology, National Tuberculosis Control Center, Sanothimi, Bhaktapur, Nepal.
Jwala K CDepartment of Pulmonology, National Tuberculosis Control Center, Sanothimi, Bhaktapur, Nepal.
Bidur KhatiwadaDepartment of Pulmonology, National Tuberculosis Control Center, Sanothimi, Bhaktapur, Nepal.
Meera HadaDepartment of Reference Lab, National Tuberculosis Control Center, Sanothimi, Bhaktapur, Nepal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSputum non-conversion is smear positive tuberculosis despite anti-tubercular therapy. Various factors may lead to sputum non-conversion including resistance to anti-tubercular drugs, age, gender, disease severity, non-compliance, drugs unavailability etc. Little is known and studied about the contribution of these individual factors. Our study sought to determine the prevalence of sputum smear non-conversion in patients at the end of intensive phase of tuberculosis treatment visiting a tertiary-level institution in Nepal.

methodsA descriptive cross-sectional study was conducted among recorded data of patients undergoing sputum Acid Fast Bacilli staining at the end of intensive phase at National Tuberculosis Control Center from April 2018 to April 2020. The study was approved by Nepal Health Research Council (Registration no: 76012020 P). The convenient sampling method was adopted. The data were analyzed using Microsoft Excel. Point estimate at 95% Confidence Interval was calculated along with frequency and proportion for binary data.

resultsOur study found that out of 830 samples that were tested by Acid Fast Bacilli stain at the end of intensive phase, 40 (4.82%) (3.37-6.28 at 95% Confidence Interval) were sputum smear non-converters. The mean age of sputum non-converters was 41.25±15.543 years.

conclusionsThe study shows that a significant proportion of patients remain acid-fast stain positive despite the treatment. However, the proportion is low compared to other similar studies around the globe. This study provides program managers with evidence to support the development of more tailored tuberculosis care and need to conduct more intensive studies about various factors that may lead to non-conversion.

Indexed as

Mycobacterium tuberculosisTuberculosis, PulmonaryAdultAntitubercular AgentsCross-Sectional StudiesHumansMiddle AgedSputumAntitubercular Agentsantitubercular agents; mycobacterium tuberculosis; tuberculosis.

Identifiers

PMID35199752
PMCPMC9124322
OpenAlexW3216739965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.